Yicong Bian
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Metabolic Stability and Metabolic Profile of Schisandrol B in Rat and Human Liver Microsomes Employing HPLC-MS/MS Analysis.
Journal: Rapid communications in mass spectrometry : RCM
Published: March 27, 2026
Single-Domain Antibody Probe with Low Renal Uptake for Claudin 18.2-Targeted PET Imaging of Gastric Cancer: Preclinical and Pilot Clinical Evaluations.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 24, 2025
Effects of Voriconazole on the Safety, Pharmacokinetics and Pharmacodynamics of Ciprofol (HSK3486), a Novel Intravenous Anaesthetic, in Healthy Participants: A Prospective, Randomized, Crossover Clinical Trial.
Journal: Drug design, development and therapy
Published: October 10, 2025
Discovery of a Potent c‑MET Inhibitor for Non-Small Cell Lung Cancer Treatment by AI-Based and Docking-Based Virtual Screening.
Journal: ACS medicinal chemistry letters
Published: August 18, 2025
Mass balance and metabolite profiles in humans of tegoprazan, a novel potassium-competitive acid blocker, using 14C-radiolabelled techniques.
Journal: Expert opinion on drug metabolism & toxicology
Published: May 11, 2025
Human dose-escalation study of PET imaging CD8+ T-cell infiltration in solid malignancies with [68Ga]Ga -NODAGA-SNA006.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 17, 2024
Absorption, metabolism, and excretion of oral [14C] radiolabeled donafenib: an open-label, phase I, single-dose study in humans.
Journal: Cancer chemotherapy and pharmacology
Published: May 27, 2024
Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study.
Journal: Expert opinion on investigational drugs
Published: January 15, 2024
A Phase I Clinical Study of the Pharmacokinetics and Safety of Prusogliptin Tablets in Subjects with Mild to Moderate Hepatic Insufficiency and Normal Liver Function.
Journal: Current drug metabolism
Published: December 01, 2023
A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans.
Journal: Frontiers in pharmacology
Published: December 05, 2022
Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy.
Journal: Chinese medical journal
Published: July 15, 2022
Last Updated: 09/26/2026